Kraig Biocraft FY26 Q2 net loss widens 25.26% to $909,535; revenue remains nilPUBT·Aug 13 at 03:41 PMKBLB+1.98%
Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare | KBLB Stock NewsStockTitan·Aug 9 at 10:05 PMKBLB+1.98%
Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk | KBLB Stock NewsStockTitan·Aug 2 at 10:05 PMKBLB+1.98%
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication | KBLB Stock NewsStockTitan·Jul 20 at 10:05 PMKBLB+1.98%
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials | KBLB Stock NewsStockTitan·Jul 9 at 10:05 PMKBLB+1.98%
Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview | KBLB Stock NewsStockTitan·Jun 14 at 10:05 PMKBLB+1.98%
Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations | KBLB Stock NewsStockTitan·May 25 at 10:35 PMKBLB+1.98%
Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform | KBLB Stock NewsStockTitan·May 19 at 10:35 PMKBLB+1.98%
Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications | KBLB Stock NewsStockTitan·May 17 at 10:05 PMKBLB+1.98%
